News | March 19, 2025
Clariant unveils natural preservation blend for cosmetics 'Nipaguard SCE Vita'
Nipaguard SCE Vita delivers comprehensive antimicrobial protection for personal care formulations
Nipaguard SCE Vita delivers comprehensive antimicrobial protection for personal care formulations
Talicia is also approved and launched in the UAE and additional countries may accept UK MHRA approvals as a reference for their own marketing approval processes
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
The MDR certification reafirms that these products meet the highest safety, quality, and regulatory standards
Overall investment in the US facility is estimated around US$50 million
The study demonstrated equivalent efficacy, safety, immunogenicity, and pharmacokinetics between YESINTEK and the reference product Stelara
ANVIMO will be available in dosages of 240 mg and 480 mg
Glenmark acquired the ANDA for Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials from Aspen Pharma USA
YESINTEK is approved for the treatment of Crohn’s disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis
Findings to form the basis for a Phase 3 program, anticipated to start in H2 2025
Subscribe To Our Newsletter & Stay Updated
